BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38494293)

  • 1. Paraneoplastic neurologic syndrome associated with gynecologic and breast malignancies.
    Peter E; Honnorat J; Desestret V
    Handb Clin Neurol; 2024; 200():409-417. PubMed ID: 38494293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
    Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
    Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
    Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
    Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
    Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
    PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
    Le May M; Dent S
    Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
    Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
    Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Discovery of Anti-Yo (Anti-PCA1) Antibody in Patients with Paraneoplastic Cerebellar Degeneration: Opening a Window into Autoimmune Neurological Disease.
    Greenlee JE; Brashear HR
    Cerebellum; 2023 Aug; 22(4):531-533. PubMed ID: 35881322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Yo positive paraneoplastic cerebellar degeneration in the setting of cholangiocarcinoma.
    Bruhnding A; Notch D; Beard A
    J Clin Neurosci; 2017 Feb; 36():71-72. PubMed ID: 27816258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer revealed by a paraneoplastic cerebellar syndrome: about one case and literature review.
    Adama D; Moussa B; Emmanuel M; Dennis U
    Pan Afr Med J; 2015; 22():25. PubMed ID: 26664526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic cerebellar degeneration in a patient with breast cancer associated with carbonic anhydrase-related protein VIII autoantibodies.
    Prevezianou A; Tzartos JS; Dagklis IE; Bentenidi E; Angelopoulos P; Bostantjopoulou S
    J Neuroimmunol; 2020 Jul; 344():577242. PubMed ID: 32325285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
    Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
    N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune and Genetic Signatures of Breast Carcinomas Triggering Anti-Yo-Associated Paraneoplastic Cerebellar Degeneration.
    Peter E; Treilleux I; Wucher V; Jougla E; Vogrig A; Pissaloux D; Paindavoine S; Berthet J; Picard G; Rogemond V; Villard M; Vincent C; Tonon L; Viari A; Honnorat J; Dubois B; Desestret V
    Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35821104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A; Stourac P; Rusina R; Sejdová M; Velenská Z
    Nervenarzt; 2002 Oct; 73(10):995-8. PubMed ID: 12376889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
    Meglic B; Graus F; Grad A
    J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pilot Study to Develop Paraneoplastic Cerebellar Degeneration Mouse Model.
    Faure F; Yshii L; Renno T; Coste I; Joubert B; Desestret V; Liblau R; Honnorat J
    Cerebellum; 2024 Feb; 23(1):181-196. PubMed ID: 36729270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraneoplastic Cerebellar Degeneration (PCD) associated with PCA-1 antibodies in established cancer patients.
    Lehner MJ; Gheeya JS; Siddiqui BA; Tummala S
    J Neurooncol; 2021 Jul; 153(3):441-446. PubMed ID: 34076832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
    Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
    Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDR2 and CDR2L line blot performance in PCA-1/anti-Yo paraneoplastic autoimmunity.
    Vorasoot N; Scharf M; Miske R; Thakolwiboon S; Dubey D; Mills JR; Pittock SJ; Zekeridou A; Ott A; McKeon A
    Front Immunol; 2023; 14():1265797. PubMed ID: 37841252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.
    Small M; Treilleux I; Couillault C; Pissaloux D; Picard G; Paindavoine S; Attignon V; Wang Q; Rogemond V; Lay S; Ray-Coquard I; Pfisterer J; Joly F; Du Bois A; Psimaras D; Bendriss-Vermare N; Caux C; Dubois B; Honnorat J; Desestret V
    Acta Neuropathol; 2018 Apr; 135(4):569-579. PubMed ID: 29299667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.